HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chanyuan Wu Selected Research

Retinal Vein Occlusion

2/2022Characteristics and risk factors of retinal vasculopathy in antiphospholipid syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chanyuan Wu Research Topics

Disease

12Dermatomyositis (Dermatopolymyositis)
01/2024 - 01/2014
9Myositis (Idiopathic Inflammatory Myopathies)
07/2023 - 04/2017
7Interstitial Lung Diseases (Interstitial Lung Disease)
11/2021 - 09/2017
6Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2023 - 01/2020
5Autoimmune Diseases (Autoimmune Disease)
01/2024 - 09/2017
5Polymyositis
11/2020 - 02/2016
4Arthritis (Polyarthritis)
12/2023 - 06/2014
3Connective Tissue Diseases (Connective Tissue Disease)
01/2021 - 01/2019
2Bacterial Infections (Bacterial Infection)
06/2023 - 01/2021
2Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
11/2022 - 02/2022
2Thrombocytopenia (Thrombopenia)
02/2022 - 01/2021
2Deglutition Disorders (Dysphagia)
01/2022 - 08/2019
1Cutaneous Lupus Erythematosus
12/2023
1Exanthema (Rash)
12/2023
1Rheumatoid Arthritis
10/2023
1Hematuria
06/2023
1Lung Diseases (Lung Disease)
01/2023
1Inflammation (Inflammations)
01/2023
1Synovitis
10/2022
1Heart Valve Diseases (Valvular Heart Disease)
02/2022
1Thrombotic Microangiopathies
02/2022
1Retinal Vein Occlusion
02/2022
1Retinal Artery Occlusion
02/2022
1Pulmonary Hypertension
11/2021
1Systemic Scleroderma (Systemic Sclerosis)
11/2021
1Fibrosis (Cirrhosis)
11/2021
1Vascular Skin Diseases
03/2021
1Infections
01/2021
1Opportunistic Infections (Opportunistic Infection)
01/2021
1Proteinuria
01/2021
1Neoplasms (Cancer)
08/2020
1Lupus Nephritis
01/2020
1Mitochondrial Diseases (Mitochondrial Disease)
01/2020
1Muscular Diseases (Myopathy)
10/2019
1Hoarseness
08/2019
1Arthralgia (Joint Pain)
08/2019
1Rheumatic Diseases (Rheumatism)
01/2018
1Genetic Predisposition to Disease (Genetic Predisposition)
02/2016
1Immunoglobulin G4-Related Disease
11/2015

Drug/Important Bio-Agent (IBA)

7AntibodiesIBA
10/2022 - 04/2017
4AutoantibodiesIBA
01/2024 - 01/2019
4Biomarkers (Surrogate Marker)IBA
01/2021 - 04/2017
3Sirolimus (Rapamycin)FDA Link
01/2022 - 01/2020
2N-phthaloylglutamic acidIBA
04/2024 - 01/2022
2Janus KinasesIBA
12/2023 - 10/2023
2cyclic citrullinated peptideIBA
10/2022 - 06/2014
2Proteins (Proteins, Gene)FDA Link
05/2022 - 01/2020
2pro-brain natriuretic peptide (1-76)IBA
01/2022 - 01/2021
2MicroRNAs (MicroRNA)IBA
11/2021 - 01/2021
2C-Reactive ProteinIBA
11/2021 - 06/2014
2CytokinesIBA
03/2021 - 01/2021
2AutoantigensIBA
01/2021 - 08/2020
2IFIH1 Interferon-Induced HelicaseIBA
01/2021 - 09/2017
2Immunosuppressive Agents (Immunosuppressants)IBA
01/2021 - 11/2015
2EnzymesIBA
11/2020 - 10/2019
1Double-Stranded RNA (RNA, Double Stranded)IBA
01/2024
1Antiviral Agents (Antivirals)IBA
01/2024
1Janus Kinase InhibitorsIBA
12/2023
1Prostaglandins AIBA
07/2023
1amsonic acid (DAS)IBA
07/2023
1Hemoglobins (Hemoglobin)IBA
06/2023
1Advanced Glycation End ProductsIBA
01/2023
1Receptor for Advanced Glycation End ProductsIBA
01/2023
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
11/2022
1Antiphospholipid AntibodiesIBA
11/2022
1Anti-Citrullinated Protein AntibodiesIBA
10/2022
1ametantrone (HAQ)IBA
03/2022
1Retinaldehyde (Retinal)IBA
02/2022
1Tacrolimus (Prograf)FDA LinkGeneric
01/2022
1Serum AlbuminIBA
01/2022
1CollagenIBA
11/2021
1Creatine Kinase (Creatine Phosphokinase)IBA
11/2021
1Immunoglobulin G (IgG)IBA
01/2021
1CreatinineIBA
01/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021
1tocilizumab (atlizumab)FDA Link
01/2021
1Nucleosomes (Nucleosome)IBA
11/2020
1ImmunosorbentsIBA
11/2020
1Surface-Active Agents (Surfactants)IBA
04/2020
1Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
04/2020
1InterferonsIBA
01/2020
1Jo-1 antibodyIBA
08/2019
1beta-cyclodextrin tetradecasulfate (CTDS)IBA
01/2019
1TYK2 Kinase (Tyrosine Kinase 2)IBA
09/2017
1DNA (Deoxyribonucleic Acid)IBA
02/2016
1Type C PhospholipasesIBA
02/2016
1GlucocorticoidsIBA
11/2015
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2014

Therapy/Procedure

2Therapeutics
01/2021 - 01/2018